Two Sigma Securities’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.3K Buy
+25,435
New +$76K 0.01% 1337
2026
Q1
Sell
-12,274
Closed -$44.3K 1629
2025
Q4
$44.3K Buy
12,274
+1,024
+9% +$4.46K 0.01% 1087
2025
Q3
$42.4K Sell
11,250
-6,861
-38% -$26.5K 0.01% 1013
2025
Q2
$70.1K Buy
+18,111
New +$98K 0.01% 1082
2023
Q2
Sell
-33,495
Closed -$141K 2739
2023
Q1
$141K Buy
+33,495
New +$398K ﹤0.01% 2149
2017
Q1
Sell
-186
Closed -$181K 881
2016
Q4
$181K Buy
+186
New +$167K 0.06% 479

Other funds holding ALT

Two Sigma Securities's ALT Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Altimmune (ALT) in Q2 2026: 25,435 shares worth $77.3K. The stake represents 0.01% of the portfolio and ranks #1337 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ALT as recently as Q4 2025.

Two Sigma Securities first reported a position in ALT in Q4 2016 and has held it in 6 quarters since. The position peaked at $181K in Q4 2016. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Two Sigma Securities held 25,435 shares of Altimmune worth $77.3K as of Q2 2026.
  • Altimmune was a new Two Sigma Securities position in Q2 2026.
  • Altimmune made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1337 holding.
  • Two Sigma Securities first reported a position in Altimmune in Q4 2016 and has held it in 6 quarters since.
  • Two Sigma Securities's Altimmune position peaked at $181K in Q4 2016.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.